Amphotericin B formulated in a lipid emulsion

被引:14
作者
Cleary, JD
机构
关键词
D O I
10.1177/106002809603000417
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:409 / 412
页数:4
相关论文
共 30 条
[1]   A CONTROLLED TRIAL OF THE TOLERANCE OF AMPHOTERICIN-B INFUSED IN DEXTROSE OR IN INTRALIPID IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES [J].
CAILLOT, D ;
RENY, G ;
SOLARY, E ;
CASASNOVAS, O ;
CHAVANET, P ;
BONNOTTE, B ;
PERELLO, L ;
DUMAS, M ;
ENTEZAM, F ;
GUY, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (03) :603-613
[2]   EFFICACY AND TOLERANCE OF AN AMPHOTERICIN-B LIPID (INTRALIPID) EMULSION IN THE TREATMENT OF CANDIDAEMIA IN NEUTROPENIC PATIENTS [J].
CAILLOT, D ;
CASASNOVAS, O ;
SOLARY, E ;
CHAVANET, P ;
BONNOTTE, B ;
RENY, G ;
ENTEZAM, F ;
LOPEZ, J ;
BONNIN, A ;
GUY, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (01) :161-169
[3]   CLINICAL-EVALUATION OF A NEW LIPID-BASED DELIVERY SYSTEM FOR INTRAVENOUS ADMINISTRATION OF AMPHOTERICIN-B [J].
CAILLOT, D ;
CHAVANET, P ;
CASASNOVAS, O ;
SOLARY, E ;
ZANETTA, G ;
BUISSON, M ;
WAGNER, O ;
CUISENIER, B ;
BONNIN, A ;
CAMERLYNCK, P ;
PORTIER, H ;
GUY, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (08) :722-725
[4]   INFLUENCE OF DIET ON EXPERIMENTAL TOXICITY OF AMPHOTERICIN-B DEOXYCHOLATE [J].
CHAVANET, P ;
JOLY, V ;
RIGAUD, D ;
BOLARD, J ;
CARBON, C ;
YENI, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) :963-968
[5]   TRIAL OF GLUCOSE VERSUS FAT EMULSION IN PREPARATION OF AMPHOTERICIN FOR USE IN HIV INFECTED PATIENTS WITH CANDIDIASIS [J].
CHAVANET, PY ;
GARRY, I ;
CHARLIER, N ;
CAILLOT, D ;
KISTERMAN, JP ;
DATHIS, M ;
PORTIER, H .
BRITISH MEDICAL JOURNAL, 1992, 305 (6859) :921-925
[6]   PHARMACOLOGICAL MODULATION OF INTERLEUKIN-1 EXPRESSION BY AMPHOTERICIN B-STIMULATED HUMAN MONONUCLEAR-CELLS [J].
CLEARY, JD ;
CHAPMAN, SW ;
NOLAN, RL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :977-981
[7]   EFFECT OF INFUSION RATE ON AMPHOTERICIN B-ASSOCIATED FEBRILE REACTIONS [J].
CLEARY, JD ;
WEISDORF, D ;
FLETCHER, CV .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (10) :769-772
[8]  
CLEARY JD, 1995, APPL THER, P69
[9]   LIPID EMULSIONS AS DRUG DELIVERY SYSTEMS [J].
DAVIS, SS ;
WASHINGTON, C ;
WEST, P ;
ILLUM, L ;
LIVERSIDGE, G ;
STERNSON, L ;
KIRSH, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 507 :75-88
[10]   LIPOSOMAL DRUG DELIVERY - ADVANTAGES AND LIMITATIONS FROM A CLINICAL PHARMACOKINETIC AND THERAPEUTIC PERSPECTIVE [J].
FIELDING, RM .
CLINICAL PHARMACOKINETICS, 1991, 21 (03) :155-164